No one is questioning that they won't receive it and no one is question that the FDA won't approve it. At this point I think it's a slam dunk.
You still wouldn't get anyone in top management to talk about something that hasn't happened yet. He'd sound more like Bianco or Berger if he did mention anything.
Market Data 
Markets 
AI
